Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
Ginkgo Bioworks
DNA
$846M
| $9K | ﹤0.01% |
918
| – | – |
2025 Q1
5 quarters
|
|
1302
Dover
DOV
$28.2B
| $9K | ﹤0.01% |
39
-11
| -22% | -$2.4K |
2024 Q3
7 quarters
|
|
1303
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$322M
| $9K | ﹤0.01% |
151
+1
| +0.7% | +$58 |
2026 Q1
1 quarter
|
|
1304
First Trust Managed Municipal ETF
FMB
$1.94B
| $9K | ﹤0.01% |
183
| – | – |
2025 Q1
5 quarters
|
|
1305
Fortive
FTV
$20B
| $9K | ﹤0.01% |
150
| – | – |
2019 Q1
29 quarters
|
|
1306
Grayscale Bitcoin Trust
GBTC
$11.2B
| $9K | ﹤0.01% |
192
| – | – |
2024 Q3
7 quarters
|
|
1307
iShares International Select Dividend ETF
IDV
$8.39B
| $9K | ﹤0.01% |
217
+5
| +2% | +$219 |
2025 Q1
5 quarters
|
|
1308
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
| $9K | ﹤0.01% |
200
| – | – |
2022 Q4
14 quarters
|
|
1309
iShares MSCI India ETF
INDA
$6.36B
| $9K | ﹤0.01% |
184
| – | – |
2022 Q4
14 quarters
|
|
1310
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.37B
| $9K | ﹤0.01% |
187
| – | – |
2021 Q1
21 quarters
|
|
1311
JPMorgan Equity Focus ETF
JPEF
$2.01B
| $9K | ﹤0.01% |
117
| – | – |
2025 Q3
3 quarters
|
|
1312
Lamar Advertising Co
LAMR
$16.2B
| $9K | ﹤0.01% |
60
+13
| +28% | +$1.88K |
2026 Q1
1 quarter
|
|
1313
Alliant Energy
LNT
$19B
| $9K | ﹤0.01% |
127
-43
| -25% | -$3.13K |
2024 Q3
7 quarters
|
|
1314
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.17B
| $9K | ﹤0.01% |
200
| – | – |
2025 Q1
5 quarters
|
|
1315
RELX
RELX
$69.3B
| $9K | ﹤0.01% |
283
| – | – |
2024 Q3
7 quarters
|
|
1316
Global X Russell 2000 Covered Call ETF
RYLD
$1.3B
| $9K | ﹤0.01% |
572
-17
| -3% | -$265 |
2025 Q2
4 quarters
|
|
1317
Urban Edge Properties
UE
$2.6B
| $9K | ﹤0.01% |
395
| – | – |
2022 Q3
15 quarters
|
|
1318
Verrica Pharmaceuticals
VRCA
$60.8M
| $9K | ﹤0.01% |
1,500
| – | – |
2024 Q3
7 quarters
|
|
1319
State Street SPDR S&P Metals & Mining ETF
XME
$3.63B
| $9K | ﹤0.01% |
85
| – | – |
2025 Q3
3 quarters
|
|
1320
NEOS Nasdaq 100 High Income ETF
QQQI
$14.7B
| $9K | ﹤0.01% |
156
-17
| -10% | -$935 |
2025 Q2
4 quarters
|
|
1321
NEOS Russell 2000 High Income ETF
IWMI
$1.34B
| $9K | ﹤0.01% |
172
-10
| -5% | -$514 |
2025 Q2
4 quarters
|
|
1322
Skydance Corporation
SKYD
$42.6B
| $9K | ﹤0.01% |
904
-18
| -2% | -$189 |
2025 Q3
3 quarters
|
|
1323
Klarna Group
KLAR
$5.08B
| $9K | ﹤0.01% |
447
-1,788
| -80% | -$28.2K |
2026 Q1
1 quarter
|
|
1324
Applied Industrial Technologies
AIT
$10.9B
| $8K | ﹤0.01% |
24
| – | – |
2025 Q3
3 quarters
|
|
1325
FT Vest Gold Strategy Quarterly Buffer ETF
BGLD
$54.5M
| $8K | ﹤0.01% |
508
| – | – |
2023 Q3
11 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.